Treatment with the drug interferon-alpha
Rheumatoid arthritis - Treatment with the drug interferon-alpha Factor
Last reviewed for CCPS 22 December 2008.
Preliminary questions [34582]
34679 there is some evidence that treatment with interferon-alpha may be a factor in the development or worsening of the condition under consideration.
34674 the veteran has been treated with interferon-alpha at some time.
the veteran was treated with interferon-alpha for an illness or injury which is identifiable.40359 — the veteran has established the causal connection between treatment with interferon-alpha and VEA service for rheumatoid arthritis.
for the identified illness or injury, the veteran was treated with interferon-alpha within the eight weeks before the clinical onset of the condition under consideration.34671 — the veteran has established the causal connection between treatment with interferon-alpha and VEA service for the clinical onset of rheumatoid arthritis.
34672 — the veteran has established the causal connection between treatment with interferon-alpha and operational service for the clinical onset of rheumatoid arthritis.
or
34673 — the veteran has established the causal connection between treatment with interferon-alpha and eligible service for the clinical onset of rheumatoid arthritis.
or
the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service. the condition under consideration permanently worsened. for the identified illness or injury, the veteran was treated with interferon-alpha within the eight weeks before the clinical worsening of the condition under consideration.40360 — the veteran has established the causal connection between treatment with interferon-alpha and VEA service for the clinical worsening of rheumatoid arthritis.
40361 — the veteran has established the causal connection between treatment with interferon-alpha and operational service for the clinical worsening of rheumatoid arthritis.
or
40362 — the veteran has established the causal connection between treatment with interferon-alpha and eligible service for the clinical worsening of rheumatoid arthritis.
Clinical onset and operational service [34672]
34677 — the identified illness or injury for which the veteran was being treated with interferon-alpha is causally related to operational service.
Clinical onset and eligible service [34673]
34678 — the identified illness or injury for which the veteran was being treated with interferon-alpha is causally related to eligible service.
Clinical worsening and operational service [40361]
34677 — the identified illness or injury for which the veteran was being treated with interferon-alpha is causally related to operational service.
the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury for which the veteran was being treated with interferon-alpha is causally related.Clinical worsening and eligible service [40362]
34678 — the identified illness or injury for which the veteran was being treated with interferon-alpha is causally related to eligible service.
the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury for which the veteran was being treated with interferon-alpha is causally related.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/rheumatoid-arthritis-n026-m05m06/rulebase-rheumatoid-arthritis/treatment-drug-interferon-alpha